We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Fosun Pharma Buys Alma Lasers

By HospiMedica International staff writers
Posted on 13 May 2013
Fosun Pharma (Shanghai, China) will spend USD 240 million to acquire up to 96.6% of Alma Lasers (Caesarea; Israel), a manufacturer of lasers used in cosmetic surgery.

Through the transaction—Fosun Pharma’s first international healthcare acquisition project—the company aims to achieve an important milestone in its strategy of developing a global business, following its initial public offering (IPO) on the H share market in Hong Kong in 2012. Fosun Pharma plans to continue its strategy of moving from product distribution to R&D and manufacturing, and gain a leading position in the international aesthetic medical device market segment.

Alma Lasers is an energy based (light, laser, radio frequency, and ultrasound) device manufacturer, with a comprehensive product offering and international sales network. Alma Lasers has developed world-class R & D capabilities in medical and cosmetic energy-based devices, as well as a leading brand name, recording nearly USD 100 million dollars total revenue in 2012; according to independent third-party research, the company has an overall 15% market share in the global high-end esthetic energy-based device segment.

“We are very optimistic about the growth prospects of the global medical and cosmetic energy-based device market, especially in the Brazil, Russia, India, and China, as well as other emerging markets,” said Qiyu Chen, chairman of Fosun Pharma. “Fosun Pharma will build on Alma's strength and be committed to developing a high-end medical device research, manufacturing platform. The acquisition demonstrates Fosun Pharma’s strategy in pursuit of global expansion.”

“Fosun's successful international M&A experience and strategic focus on healthcare and aesthetic and medical devices provide Alma Lasers with an exceptional platform to grow our business in Asia and globally,” said Ziv Karni, CEO of Alma Lasers. “We look forward to working with the management team of Fosun and benefiting from their expertise.”

Related Links:

Fosun Pharma
Alma Lasers



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
LED Examination Lamp
Clarity 50 LED
New
Phototherapy Eye Protector
EyeMax2

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex